$ALMS
Alumis Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$7.80
▼-0.26%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAlumis Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ALMS down today? It is at $7.80 (-0.26%), and our scanner flagged it 262 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALMS spikes, and full due diligence on ALMS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALMS 262 times in the last 30 days. Create a free account to track $ALMS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ALMS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALMS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akkaraju Srinivas Director | Sold (automatic/other) | -96K 0.07% of company | sold 4.5% | 2.03M | $1.0M at $10.55 | Sep 8, 26 |
Akkaraju Srinivas Director | Bought (open market) | +547K 0.4% of company | added 8.2% | 7.24M | $5.8M at $10.63 | Sep 8, 26 |
Akkaraju Srinivas Director | Bought (open market) | +440K 0.3% of company | added 10% | 4.71M | $4.9M at $11.17 | Sep 4, 26 |
Bradley Mark Christopher Officer | Sold (automatic/other) | -3K | sold 5.0% | 49K | $68K at $26.37 | Aug 3, 26 |
Drappa Jorn Officer | Sold (automatic/other) | -2K | sold 4.1% | 57K | $65K at $26.37 | Aug 3, 26 |
Goldstein David M Officer | Sold (automatic/other) | -3K | sold 7.7% | 31K | $68K at $26.37 | Aug 3, 26 |
Hardiman Roy C. Officer | Sold (automatic/other) | -3K | sold 1.3% | 208K | $71K at $26.37 | Aug 3, 26 |
Pangali Sanam Officer | Sold (automatic/other) | -1K | sold 12% | 10K | $36K at $26.37 | Aug 3, 26 |
Schroer John R. Officer | Sold (automatic/other) | -3K | sold 12% | 25K | $87K at $26.37 | Aug 3, 26 |
Pangali Sanam Officer | Sold (automatic/other) | -5K | sold 31% | 11K | $140K at $28.00 | Jul 6, 26 |
Pangali Sanam Officer | Other | 5K | added 45% | 16K | $25K at $5.06 | Jul 6, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +4K | n/a | 4K | n/a | Jun 30, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ALMS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALMS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ALMS last traded at $7.80, down 0.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Alumis Inc. Common Stock (ALMS) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALMS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALMS 262 times in the last 30 days.
ALMS (Alumis Inc. Common Stock) trades on XNAS, with a market cap of about $1.01B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALMS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALMS discussion
Sign in to ask a question or join the discussion.